Clinical Trial Update: Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Abiraterone Acetate in men with castration-resistant prostate cancer previously treated with docetaxel completed. Results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Zytiga (abiraterone acetate)

Snippet

Sponsor: Cougar Biotechnology, Inc. | Conditions: Prostatic Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2013-05-16